-
Study aim
-
Comparison of the severity of depression before and after taking the hydroalcoholic extract of Danai Dracocephalum kotschyi Boiss plant in patients referred to the psychiatric clinic.
-
Design
-
A clinical trial with a control group, with parallel groups, without blinding, non-random, phase 3 on 74 patients, the collected data will be entered into the computer and will be analyzed by spss software version 25.
-
Settings and conduct
-
In the control group, S-Citalopram tablets, 10 mg daily, for 1 month, and in the intervention group, in addition to the same dose of S-Citalopram, a dose of 500 mg of the hydroalcoholic extract of the studied plant (one daily capsule) was given by a specialist doctor after explanation. The exact method of use is given to the patient. Patients are visited and medicine is prescribed in Shahid Muftah educational and therapeutic clinic. The participants take the medicines at home and The place of study is Yasouj University of Medical Sciences.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Diagnosis of mild to moderate depression based on clinical interview and depression questionnaire
Exclusion criteria:
Contraindications for taking extract of Danai Dracocephalum kotschyi Boiss plant (such as allergy to herbal medicine)
-
Intervention groups
-
The Beck and Hamilton Depression Questionnaire is completed at time zero (before the intervention) and 30 days after the start of treatment for all patients. In the control group, S-citalopram tablets , 10 mg daily, for 1 month, and in the intervention group, in addition to the same dose of S-citalopram, a dose of 500 mg of the hydroalcoholic extract of the studied plant (one daily capsule) was administered by a specialist doctor after explanation. The exact method of use is given to the patient. . 1 month after the treatment, re-evaluation (post-test) is done using the Beck and Hamilton Depression Questionnaire.
-
Main outcome variables
-
The level of depression